Markers for Obese and Non-obese Type 2 Diabetes Identified Using Whole Blood Metabolomics

Overview

Journal Sci Rep

Specialty Science

Date 2023 Feb 11

PMID 36774491

Authors

Takayuki Teruya

Sumito Sunagawa

Ayaka Mori

Hiroaki Masuzaki

Mitsuhiro Yanagida

Affiliations

Soon will be listed here.

Abstract

Definitive differences in blood metabolite profiles between obese and non-obese Type 2 diabetes (T2D) have not been established. We performed an LC-MS-based non-targeted metabolomic analysis of whole blood samples collected from subjects classified into 4 types, based on the presence or absence of obesity and T2D. Of the 125 compounds identified, 20, comprising mainly nucleobases and glucose metabolites, showed significant increases or decreases in the T2D group. These included cytidine, UDP-glucuronate, UMP, 6-phosphogluconate, and pentose-phosphate. Among those 20 compounds, 11 enriched in red blood cells (RBCs) have rarely been studied in the context of diabetes, indicating that RBC metabolism is more extensively disrupted than previously known. Correlation analysis revealed that these T2D markers include 15 HbA1c-associated and 5 irrelevant compounds that may reflect diabetic conditions by a different mechanism than that of HbA1c. In the obese group, enhanced protein and fatty acid catabolism causes increases in 13 compounds, including methylated or acetylated amino acids and short-chain carnitines. Our study, which may be considered a pilot investigation, suggests that changes in blood metabolism due to obesity and diabetes are large, but essentially independent.

Citing Articles

Lean diabetes: 20-year trends in its prevalence and clinical features among Korean adults.

Kim J, Joung K, Kim H, Ku B, Jung S, Lee J BMC Public Health. 2024; 24(1):3554.

PMID: 39707280 PMC: 11662422. DOI: 10.1186/s12889-024-21034-2.

Profiling of Metabolome in the Plasma Following a circH19 Knockdown Intervention in Diet-Induced Obese Mice.

Zhao H, Shi D, Gui W, Lin X, Chen J, Yu W Metabolites. 2024; 14(11).

PMID: 39590839 PMC: 11596236. DOI: 10.3390/metabo14110603.

Adipocytokines and Inflammation in Patients and a Gerbil Model: Implications for Obesity-Related and Nonobese Diabetes.

Fang H, Li X, Lv J, Huo X, Guo M, Liu X J Diabetes Res. 2024; 2024:9683512.

PMID: 39474247 PMC: 11521580. DOI: 10.1155/2024/9683512.

An Overview of Pre-Analytical Factors Impacting Metabolomics Analyses of Blood Samples.

Thachil A, Wang L, Mandal R, Wishart D, Blydt-Hansen T Metabolites. 2024; 14(9).

PMID: 39330481 PMC: 11433674. DOI: 10.3390/metabo14090474.

The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity.

Jedrysik M, Wyszomirski K, Rozanska-Waledziak A, Grosicka-Maciag E, Waledziak M, Chelstowska B Biomedicines. 2024; 12(1).

PMID: 38255264 PMC: 10813748. DOI: 10.3390/biomedicines12010159.

References

Gil A, Siegel D, Permentier H, Reijngoud D, Dekker F, Bischoff R . Stability of energy metabolites-An often overlooked issue in metabolomics studies: A review. Electrophoresis. 2015; 36(18):2156-2169. DOI: 10.1002/elps.201500031. View

Welle S, Barnard R, Statt M, Amatruda J . Increased protein turnover in obese women. Metabolism. 1992; 41(9):1028-34. DOI: 10.1016/0026-0495(92)90133-U. View

Pluskal T, Nakamura T, Villar-Briones A, Yanagida M . Metabolic profiling of the fission yeast S. pombe: quantification of compounds under different temperatures and genetic perturbation. Mol Biosyst. 2009; 6(1):182-98. DOI: 10.1039/b908784b. View

Yoon K, Lee J, Kim J, Cho J, Choi Y, Ko S . Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006; 368(9548):1681-8. DOI: 10.1016/S0140-6736(06)69703-1. View

Newgard C, An J, Bain J, Muehlbauer M, Stevens R, Lien L . A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009; 9(4):311-26. PMC: 3640280. DOI: 10.1016/j.cmet.2009.02.002. View

van Doorn M, Vogels J, Tas A, van Hoogdalem E, Burggraaf J, Cohen A . Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol. 2007; 63(5):562-74. PMC: 2000756. DOI: 10.1111/j.1365-2125.2006.02816.x. View

Kameda M, Teruya T, Yanagida M, Kondoh H . Reduced uremic metabolites are prominent feature of sarcopenia, distinct from antioxidative markers for frailty. Aging (Albany NY). 2021; 13(17):20915-20934. PMC: 8457568. DOI: 10.18632/aging.203498. View

Kim M, Jung H, Hwang-Bo Y, Cho S, Jang H, Kim S . Evaluation of 1,5-anhydroglucitol as a marker for glycemic variability in patients with type 2 diabetes mellitus. Acta Diabetol. 2011; 50(4):505-10. DOI: 10.1007/s00592-011-0302-0. View

Pluskal T, Castillo S, Villar-Briones A, Oresic M . MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010; 11:395. PMC: 2918584. DOI: 10.1186/1471-2105-11-395. View

10.

Fiehn O, Garvey W, Newman J, Lok K, Hoppel C, Adams S . Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One. 2010; 5(12):e15234. PMC: 3000813. DOI: 10.1371/journal.pone.0015234. View

11.

Sass J, Mohr V, Olbrich H, Engelke U, Horvath J, Fliegauf M . Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet. 2006; 78(3):401-9. PMC: 1380284. DOI: 10.1086/500563. View

12.

Mai M, Tonjes A, Kovacs P, Stumvoll M, Fiedler G, Leichtle A . Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS One. 2013; 8(12):e82459. PMC: 3865089. DOI: 10.1371/journal.pone.0082459. View

13.

Lee W, Lee H, Jang H, Kim H, Ban H, Kim K . Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle. Sci Rep. 2018; 8(1):2133. PMC: 5794993. DOI: 10.1038/s41598-018-20549-0. View

14.

Yin P, Lehmann R, Xu G . Effects of pre-analytical processes on blood samples used in metabolomics studies. Anal Bioanal Chem. 2015; 407(17):4879-92. PMC: 4471316. DOI: 10.1007/s00216-015-8565-x. View

15.

Drogan D, Dunn W, Lin W, Buijsse B, Schulze M, Langenberg C . Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study. Clin Chem. 2014; 61(3):487-97. DOI: 10.1373/clinchem.2014.228965. View

16.

Eid H, Arnesen H, Hjerkinn E, Lyberg T, Seljeflot I . Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism. 2004; 53(12):1574-9. DOI: 10.1016/j.metabol.2004.06.026. View

17.

Chaleckis R, Murakami I, Takada J, Kondoh H, Yanagida M . Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci U S A. 2016; 113(16):4252-9. PMC: 4843419. DOI: 10.1073/pnas.1603023113. View

18.

Davydova E, Shimazu T, Schuhmacher M, Jakobsson M, Willemen H, Liu T . The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes. Nat Commun. 2021; 12(1):891. PMC: 7873184. DOI: 10.1038/s41467-020-20670-7. View

19.

Tuck M, Cox R . Ethionine inhibits in vivo methylation of nuclear proteins. Carcinogenesis. 1982; 3(4):431-4. DOI: 10.1093/carcin/3.4.431. View

20.

Jensen M, Haymond M . Protein metabolism in obesity: effects of body fat distribution and hyperinsulinemia on leucine turnover. Am J Clin Nutr. 1991; 53(1):172-6. DOI: 10.1093/ajcn/53.1.172. View